pfizer glp-1 news Stops Work on Oral Obesity Drug After Safety Signal Surfaces in Clinical Trial Pfizer secures rights to new
Description
But here is where it gets interesting
Stops Glucagon : GLP-1 inhibits glucagon, a hormone that raises blood sugar, helping to prevent spikes
It is biology at work
Dis Manag (2007) 10(3):12937.10.1089/dis.2007.103643 7 MaggardMAShugarmanLRSuttorpMMaglioneMSugermanHJLivingstonEHet alMeta-analysis: surgical treatment of obesity
All exciting for the future of humanity nonetheless.
